Edgestream Partners »

Ultragenyx Pharmaceutical shares owned by Edgestream Partners

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 100k 23.00
2023-03-31 $267k 6.7k 40.10
2022-09-30 $709k 17k 41.44

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Goldman Sachs (GS)
Stryker Corporation (SYK)
Abbvie (ABBV)
Jones Lang LaSalle Incorporated (JLL)
Reliance Steel & Aluminum (RS)

View all positions for Edgestream Partners

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Frontier Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical